Navigation Links
Entries Still Open for US Clinical Researcher of the Year 2012 Competition
Date:7/31/2012

LONDON, July 31, 2012 /PRNewswire/ --

There is still time to enter the US Clinical Researcher of the Year competition, whose theme this year focuses on using resources more effectively without compromising patient safety or quality of data.

The competition welcomes participants from the following areas of research:

  • Study Nurse/Clinical Research Coordinator
  • Clinical Research Associates (with varying levels of experience)
  • Project Manager working within a CRO environment
  • Study Leader working within a pharma/sponsor environment
  • Clinical Trial Teams

Entries are building fast with engagement from a broad cross-section of CRO and pharma competitors including: PRA, PPD, Parexel, Chiltern, INC Research, Shire Pharmaceuticals, GSK, Sanofi, Benchmark Research, Endo Pharmaceuticals, MSD, Abbott and Allergan.

Professionals within the clinical research fraternity are able to compete on a level playing field in this competition, working through a series of competency-based exercises that start with a multiple-choice questionnaire based on ICH/GCP and end with a case-study devised to explore different approaches to risk-based or targeted monitoring.

Organised by media company PharmaTimes, the competition is independently judged by a high level Executive Steering Committee drawn from senior pharma clinical leaders within AZ, GSK, MSD, Sanofi, Shire, Endo Pharma, Allergan, Alcon and Stiefel.

Finals day and presentation of the US Clinical Researcher of the Year awards will take place on 8 November and will be hosted by competition sponsors, SAS, at their Executive Briefing Centre in Cary, North Carolina.

Closing date for entry to the competition is 7 September. For more information and/or to enter the competition please go to http://www.usclinicalresearcher.com.

Contacts: Sean Morgan-Jones - +44(0)208-8788566 - email: sean@pharmatimes.com.



'/>"/>
SOURCE Pharma Times
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Call for Entries: International Bureau for Epilepsy and UCB launch the 2012 Excellence in Epilepsy Journalism Award to recognize exceptional reporting on epilepsy
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
3. Disability Advocates Tell Medicare: Use a Clinical Template to Accurately Document Medical Need for Wheelchairs
4. Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
5. PRA Participates in Landmark Alzheimers Prevention Clinical Trial
6. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
7. Chimerixs Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
8. Berg Pharma launches clinical trial on BPM 31543 for prevention of chemotherapy-induced alopecia (CIA)
9. Caspase Inhibitor Enters Clinical Trial In Islet Transplantation As Treatment For Diabetes
10. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
11. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):